Samsung Medison, the medical device division of Samsung Electronics renowned for its diagnostic imaging technology, announced its intention to acquire Sonio, a Paris-based startup specializing in AI-powered ultrasound software, for approximately $92.7 million (KRW 126 billion).
Sonio’s innovative AI assistant is tailored to support obstetricians and gynecologists in evaluating and documenting ultrasound examinations. Notably, its flagship product, Sonio Detect, has obtained regulatory clearance from the United States Food and Drug Administration (FDA 510(k)), utilizing deep learning algorithms to enhance real-time ultrasound image quality.
Samsung Medison’s Vision for AI-Driven Imaging
By integrating Sonio’s software into its portfolio, Samsung Medison aims to revolutionize imaging workflows through advanced AI technology. This strategic acquisition aligns with Samsung Electronics’ commitment to enhancing healthcare solutions, leveraging its majority stake (68.45%) in Samsung Medison, acquired through the $22 million purchase of Medison in 2011.
Following the acquisition, it assures that Sonio will retain its autonomy as an independent entity, maintaining its commercial growth trajectory and product offerings in France. This approach further underscores Samsung Medison’s respect for Sonio’s entrepreneurial spirit and commitment to innovation.
Founders’ Vision and Investment Journey
Founded in 2020 by Cecile Brosset (CEO) and Rémi Besson (CSO), Sonio has secured significant funding, including a $14 million Series A round led by Cross Border Impact Ventures in August 2023. With total funding amounting to $27.2 million, Sonio has garnered support from prominent investors such as Elaia, Bpifrance French Tech Seed, OneRagtime, and several angel investors.
Yong Kwan Kim the CEO, envisions a synergistic partnership with Sonio, poised to elevate prenatal ultrasound examinations through cutting-edge technology. Cecile Brosset, CEO of Sonio, echoes this sentiment, emphasizing the growth potential inherent in combining Samsung Medison’s global ultrasound expertise with Sonio’s AI capabilities. Together, they aspire to redefine medical reporting technology and diagnostic software, further catering to diverse healthcare needs worldwide, including underserved communities.
Samsung Medison’s strategic acquisition of Sonio underscores its commitment to advancing healthcare technology. With a focus on innovation and collaboration, the partnership between Samsung Medison and Sonio nevertheless promises to drive transformative change in medical imaging, ultimately improving patient outcomes and quality of life.
See also: Panax Secures $10M Series A For AI-Powered Cash Flow Management Platform
